Form 4 for DRMA Dermata Therapeutics, Inc.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-02-17 · accession 0001493152-26-010630 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-17 | 2026-02-17 | DRMA | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | P - Purchase | $1.27 | +1,000 | 1,012 | +8,333% | +$1,270 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | P | A | 1,000 | $1.27 | 1,012 | D | — | — |